Iterum Therapeutics plc (ITRMF)
OTCMKTS · Delayed Price · Currency is USD
0.0450
0.00 (0.00%)
At close: May 18, 2026
Iterum Therapeutics Market Cap
Iterum Therapeutics has a market cap or net worth of $2.38 million as of May 19, 2026. Its market cap has decreased by -94.32% in one year.
Market Cap
2.38M
Enterprise Value
25.11M
Revenue
390.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since May 25, 2018, Iterum Therapeutics's market cap has decreased from 179.38M to 2.38M, a decrease of -98.67%. That is a compound annual growth rate of -41.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 2.38M | -86.57% |
| Dec 31, 2025 | 17.70M | -63.66% |
| Dec 31, 2024 | 48.70M | 84.01% |
| Dec 29, 2023 | 26.47M | 157.57% |
| Dec 30, 2022 | 10.28M | -85.65% |
| Dec 31, 2021 | 71.61M | 47.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CASI Pharmaceuticals | 3.08M |
| Vaccinex | 2.94M |
| Hepion Pharmaceuticals | 2.71M |
| Enzolytics | 2.66M |
| VitaSpring Biomedical | 2.30M |
| ProtoKinetix | 2.22M |
| Burzynski Research Institute | 2.07M |
| AXIM Biotechnologies | 2.06M |